Your browser doesn't support javascript.
loading
Nanomolar Protein-Protein Interaction Monitoring with a Label-Free Protein-Probe Technique.
Valtonen, Salla; Vuorinen, Emmiliisa; Kariniemi, Taru; Eskonen, Ville; Le Quesne, John; Bushell, Martin; Härmä, Harri; Kopra, Kari.
Affiliation
  • Valtonen S; Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
  • Vuorinen E; Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
  • Kariniemi T; Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
  • Eskonen V; Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
  • Le Quesne J; University of Cambridge, MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 7HB, U.K.
  • Bushell M; Cancer Research U.K. Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.
  • Härmä H; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, U.K.
  • Kopra K; Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
Anal Chem ; 92(24): 15781-15788, 2020 12 15.
Article in En | MEDLINE | ID: mdl-33237744
ABSTRACT
Protein-protein interactions (PPIs) are an essential part of correct cellular functionality, making them increasingly interesting drug targets. While Förster resonance energy transfer-based methods have traditionally been widely used for PPI studies, label-free techniques have recently drawn significant attention. These methods are ideal for studying PPIs, most importantly as there is no need for labeling of either interaction partner, reducing potential interferences and overall costs. Already, several different label-free methods are available, such as differential scanning calorimetry and surface plasmon resonance, but these biophysical methods suffer from low to medium throughput, which reduces suitability for high-throughput screening (HTS) of PPI inhibitors. Differential scanning fluorimetry, utilizing external fluorescent probes, is an HTS compatible technique, but high protein concentration is needed for experiments. To improve the current concepts, we have developed a method based on time-resolved luminescence, enabling PPI monitoring even at low nanomolar protein concentrations. This method, called the protein probe technique, is based on a peptide conjugated with Eu3+ chelate, and it has already been applied to monitor protein structural changes and small molecule interactions at elevated temperatures. Here, the applicability of the protein probe technique was demonstrated by monitoring single-protein pairing and multiprotein complexes at room and elevated temperatures. The concept functionality was proven by using both artificial and multiple natural protein pairs, such as KRAS and eIF4A together with their binding partners, and C-reactive protein in a complex with its antibody.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Chelating Agents / Proto-Oncogene Proteins p21(ras) / Eukaryotic Initiation Factor-4A / Europium Limits: Humans Language: En Journal: Anal Chem Year: 2020 Type: Article Affiliation country: Finland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Chelating Agents / Proto-Oncogene Proteins p21(ras) / Eukaryotic Initiation Factor-4A / Europium Limits: Humans Language: En Journal: Anal Chem Year: 2020 Type: Article Affiliation country: Finland